I think the hypothetical question here is: if someone was offered 20 -30 dollars per share right now, would they take it?
that's 5-8 times the SP now. I believe most would say yes(personal opinion), despite what the board would suggest. That is a massive increase in someone's investment and not common in most instances.
I feel the board has an intrinsic value in their minds, and it's closer to the value of keytruda than it is magrolimab(forty seven).
my opinion: they've done the in depth research into how high a chance this will translate from pre clinical to humans. I reckon they believe based on the science that this is high. Their biggest risk is designing the trial, although I feel this may be easier than trying to prove something over standard of care, as to get a patient or doctor to try something over the well known treatment is quite difficult. I may be completely out of my depth with this assumption, and if so I hope someone can correct me.
- Forums
- ASX - By Stock
- RAC
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-121
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.66 |
Change
-0.020(1.19%) |
Mkt cap ! $282.8M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.61 | $118.5K | 72.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 601 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.650 |
1 | 276 | 1.630 |
1 | 2000 | 1.625 |
2 | 1025 | 1.620 |
1 | 3000 | 1.615 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 601 | 1 |
1.700 | 6382 | 1 |
1.720 | 580 | 1 |
1.730 | 309 | 1 |
1.735 | 609 | 1 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |